Results 271 to 280 of about 212,526 (280)

Angiogenesis Inhibitors: Current Strategies and Future Prospects

Ca-A Cancer Journal for Clinicians, 2010
Kristina M Cook, William D Figg
exaly  

Juxtamembrane autoinhibition in receptor tyrosine kinases

Nature Reviews Molecular Cell Biology, 2004
Stevan R Hubbard
exaly  

Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management

Ca-A Cancer Journal for Clinicians
Maxime Borgeaud, Jair Bar, Stephanie Saw
exaly  

Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology

Nature Reviews Cancer, 2013
Bengt Hallberg, Ruth H Palmer
exaly  

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

Lancet, The, 2005
exaly  

Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions

Nature, 1995
Bernardo Rudy
exaly  

Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?

Nature Reviews Clinical Oncology, 2016
Gianantonio Rosti, Fausto Castagnetti, Michele Baccarani   +2 more
exaly  

Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF

Nature, 1991
Luis F Parada
exaly  

Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase

Cell, 1993
Lawrence S Argetsinger, James N Ihle, Christin Carter-Su   +2 more
exaly  

Tyrosine kinase gene rearrangements in epithelial malignancies

Nature Reviews Cancer, 2013
exaly